These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 22391209)
1. Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development. Caracciolo V; Laurenti G; Romano G; Carnevale V; Cimini AM; Crozier-Fitzgerald C; Gentile Warschauer E; Russo G; Giordano A Cell Cycle; 2012 Mar; 11(6):1202-16. PubMed ID: 22391209 [TBL] [Abstract][Full Text] [Related]
2. Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7. Tamrakar S; Kapasi AJ; Spector DH J Virol; 2005 Dec; 79(24):15477-93. PubMed ID: 16306619 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia. Yeh YY; Chen R; Hessler J; Mahoney E; Lehman AM; Heerema NA; Grever MR; Plunkett W; Byrd JC; Johnson AJ Oncotarget; 2015 Feb; 6(5):2667-79. PubMed ID: 25596730 [TBL] [Abstract][Full Text] [Related]
4. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664 [TBL] [Abstract][Full Text] [Related]
5. CDK9 inhibition strategy defines distinct sets of target genes. Garriga J; GraƱa X BMC Res Notes; 2014 May; 7():301. PubMed ID: 24886624 [TBL] [Abstract][Full Text] [Related]
6. The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression. Hou T; Ray S; Brasier AR J Biol Chem; 2007 Dec; 282(51):37091-102. PubMed ID: 17956865 [TBL] [Abstract][Full Text] [Related]
7. TFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase II. Glover-Cutter K; Larochelle S; Erickson B; Zhang C; Shokat K; Fisher RP; Bentley DL Mol Cell Biol; 2009 Oct; 29(20):5455-64. PubMed ID: 19667075 [TBL] [Abstract][Full Text] [Related]
9. The CDK9/cyclin T1 subunits of P-TEFb in mouse oocytes and preimplantation embryos: a possible role in embryonic genome activation. Oqani RK; Kim HR; Diao YF; Park CS; Jin DI BMC Dev Biol; 2011 Jun; 11():33. PubMed ID: 21639898 [TBL] [Abstract][Full Text] [Related]
10. CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation. Gordon V; Bhadel S; Wunderlich W; Zhang J; Ficarro SB; Mollah SA; Shabanowitz J; Hunt DF; Xenarios I; Hahn WC; Conaway M; Carey MF; Gioeli D Mol Endocrinol; 2010 Dec; 24(12):2267-80. PubMed ID: 20980437 [TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway. Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the cyclin-dependent kinases at the beginning of human cytomegalovirus infection specifically alters the levels and localization of the RNA polymerase II carboxyl-terminal domain kinases cdk9 and cdk7 at the viral transcriptosome. Kapasi AJ; Spector DH J Virol; 2008 Jan; 82(1):394-407. PubMed ID: 17942543 [TBL] [Abstract][Full Text] [Related]
14. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes. Dow EC; Liu H; Rice AP J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II. Napolitano G; Majello B; Licciardo P; Giordano A; Lania L Gene; 2000 Aug; 254(1-2):139-45. PubMed ID: 10974544 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of cdk9 during herpes simplex virus 1 infection impedes viral transcription. Ou M; Sandri-Goldin RM PLoS One; 2013; 8(10):e79007. PubMed ID: 24205359 [TBL] [Abstract][Full Text] [Related]
17. Xylocydine, a novel Cdk inhibitor, is an effective inducer of apoptosis in hepatocellular carcinoma cells in vitro and in vivo. Cho SJ; Lee SS; Kim YJ; Park BD; Choi JS; Liu L; Ham YM; Moon Kim B; Lee SK Cancer Lett; 2010 Jan; 287(2):196-206. PubMed ID: 19616371 [TBL] [Abstract][Full Text] [Related]
18. Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II. Watanabe Y; Fujimoto H; Watanabe T; Maekawa T; Masutani C; Hanaoka F; Ohkuma Y Genes Cells; 2000 May; 5(5):407-23. PubMed ID: 10886368 [TBL] [Abstract][Full Text] [Related]
19. Binding to DNA of the RNA-polymerase II C-terminal domain allows discrimination between Cdk7 and Cdk9 phosphorylation. Lolli G Nucleic Acids Res; 2009 Mar; 37(4):1260-8. PubMed ID: 19136461 [TBL] [Abstract][Full Text] [Related]
20. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]